Pelvital's Flyte: A Beacon of Hope for Women's Health
April 23, 2024, 9:32 pm
Location: United States, Minnesota, Minneapolis
Employees: 1-10
Founded date: 2016
Total raised: $5.24M
Pelvital USA, Inc., a women's health company based in Eagan, MN, has secured an additional $2.32M in seed-plus funding to propel the commercialization of Flyte, their groundbreaking FDA-cleared treatment for stress urinary incontinence (SUI) and weakened pelvic floor muscles. Led by Lydia Zeller, President and CEO, Pelvital is on a mission to empower women and clinicians to restore pelvic health with effective, evidence-based products.
Flyte, a transvaginal mechanotherapy device, offers a ray of hope for the millions of women in the US suffering from urinary incontinence. With SUI being a common issue post-partum, Pelvital aims to break the stigma surrounding UI and provide a non-invasive, at-home solution for women of all ages. The typical treatment regimen of five minutes per day for six weeks has shown promising results for women with mild to severe SUI.
The barriers to care for UI are numerous, including stigmatization, lack of access to conservative treatments, and misinformation. Pelvital's Flyte seeks to bridge these gaps by offering expert support from Doctors of Physical Therapy specializing in pelvic health. The company's commitment to providing a first-line, conservative treatment option for clinicians is evident in their efforts to expand insurance coverage and advocate for routine screening for UI in primary care settings.
With Flyte, Pelvital aims to revolutionize the way women approach urinary incontinence, offering a safe, effective alternative to surgery and in-person treatments. The ultimate goal is to make Flyte the gold standard of conservative care for UI, ensuring that all women have access to this life-changing technology. As Preetha Ram, Managing Partner at Pier 70 Ventures, joins Pelvital's Board of Directors, the company is poised to make a significant impact in the field of women's health.
In a world where UI is often dismissed as a normal part of aging or motherhood, Pelvital's Flyte shines as a beacon of hope for women seeking relief from the burdens of urinary incontinence. With a strong focus on clinical evidence and patient outcomes, Pelvital is paving the way for a future where women can reclaim their pelvic health and live their lives to the fullest.
Flyte, a transvaginal mechanotherapy device, offers a ray of hope for the millions of women in the US suffering from urinary incontinence. With SUI being a common issue post-partum, Pelvital aims to break the stigma surrounding UI and provide a non-invasive, at-home solution for women of all ages. The typical treatment regimen of five minutes per day for six weeks has shown promising results for women with mild to severe SUI.
The barriers to care for UI are numerous, including stigmatization, lack of access to conservative treatments, and misinformation. Pelvital's Flyte seeks to bridge these gaps by offering expert support from Doctors of Physical Therapy specializing in pelvic health. The company's commitment to providing a first-line, conservative treatment option for clinicians is evident in their efforts to expand insurance coverage and advocate for routine screening for UI in primary care settings.
With Flyte, Pelvital aims to revolutionize the way women approach urinary incontinence, offering a safe, effective alternative to surgery and in-person treatments. The ultimate goal is to make Flyte the gold standard of conservative care for UI, ensuring that all women have access to this life-changing technology. As Preetha Ram, Managing Partner at Pier 70 Ventures, joins Pelvital's Board of Directors, the company is poised to make a significant impact in the field of women's health.
In a world where UI is often dismissed as a normal part of aging or motherhood, Pelvital's Flyte shines as a beacon of hope for women seeking relief from the burdens of urinary incontinence. With a strong focus on clinical evidence and patient outcomes, Pelvital is paving the way for a future where women can reclaim their pelvic health and live their lives to the fullest.